The Food and Drug Administration (FDA) asked a federal judge on Nov. 15 to give it until the year 2076 to fully release the documents in its possession tied to the approval of the Pfizer-BioNTech COVID-19 vaccine.
The plaintiff, Public Health and Medical Professionals for Transparency (PHMPT), is a group of doctors and scientists, including Harvey Risch, a professor of epidemiology at the Yale School of Public Health.
“It took the FDA precisely 108 days from when Pfizer started producing the records for licensure to when the FDA licensed the Pfizer vaccine,” Siri continued. “Taking the FDA at its word, it conducted an intense, robust, thorough, and complete review and analysis of those documents in order to assure that the Pfizer vaccine was safe and effective for licensure. While it can conduct that intense review of Pfizer’s documents in 108 days, it now asks for over 20,000 days to make these documents available to the public.”
The FDA did not respond to a request for comment.
The FDA licensed the Pfizer COVID-19 vaccine under the Comirnaty label on Aug. 23, 2021, less than four months after Pfizer began submitting documents for full approval of the drug. The FDA approval of the license in late August led to an avalanche of vaccine mandates in the private and public sectors.
The whistleblower, Brook Jackson, alerted the FDA and was fired within hours. Jackson was working for Ventavia Research Group, which operated several of the Pfizer trial sites in the fall of 2020.
The FDA told The Epoch Times in an email earlier this month that while it can’t comment on the Ventavia matter, it “has full confidence in the data that were used to support the Pfizer-BioNTech COVID-19 vaccine authorization and the Comirnaty approval.”